Medicine and Dentistry
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
83%
Vaccine Efficacy
57%
Infection
44%
Interim Analysis
41%
Nucleic Acid Amplification
40%
Immune Response
33%
Tumor Immunity
33%
Single Drug Dose
33%
Thrombophlebitis
33%
Randomized Controlled Trial
33%
Pooled Analysis
33%
Prevalence
33%
Antiinfective Agent
33%
Booster Dose
33%
Immunogenicity
33%
Cancer Therapy
25%
Virus Particle
23%
Low Drug Dose
21%
Diseases
21%
Antibody Response
16%
Biomedical Research
14%
Adverse Event
14%
Table Salt
14%
Clinical Research
14%
Pathogen
13%
Pulmonary Embolism
13%
Immunoassay
8%
Placebo
8%
Neutralization
8%
Coughing
8%
Anosmia
8%
Solid Malignant Neoplasm
8%
Dyspnea
8%
Infection Rate
8%
Medicine
8%
Guanine Nucleotide Binding Protein
8%
Ageusia
8%
Streptococcus
6%
Blood Culture
6%
Anticoagulation
6%
Observational Study
6%
Surgical Drainage
6%
Antimicrobial Therapy
6%
Abscess
6%
Opiate Substitution Treatment
6%
Arm
6%
Conjugate Vaccine
6%
Clinical Trial
6%
Gram-Negative Bacteria
6%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
50%
Nucleic Acid Amplification
50%
Low Drug Dose
41%
RNA Binding
33%
Proteome
33%
Virus Particle
33%
Single Drug Dose
33%
Randomized Controlled Trial
33%
Immunogenicity
33%
Clinical Research
25%
Antibody Response
16%
Clinical Trial
16%
RNA
13%
Binding Site
13%
Breathing
8%
Immunoassay
8%
G Protein
8%
RNA-binding Protein
6%
Amino Acids
6%
Proteomics
6%
Nursing and Health Professions
Severe Acute Respiratory Syndrome
33%
Malignant Neoplasm
33%
Longitudinal Analysis
33%
Prevalence
33%
Cancer Therapy
25%
Infection
12%
Solid Malignant Neoplasm
8%
Infection Rate
8%
